Retatrutide
Reta
Triple agonist peptide (GLP-1 / GIP / Glucagon)
$165
per vial
Bundle pricing
1 vial
$165
2 vials
$155 ea
3+ vials
$150 ea
For research purposes only. Not for human consumption.
Overview
Retatrutide is a novel triple receptor agonist investigated in research models for its activity across GLP-1, GIP, and glucagon receptors.
Research applications
- Metabolic pathway studies
- Receptor binding affinity research
- Adipose tissue model investigations
Specifications
- Dose
- 10 mg / vial
- Purity
- ≥99%
- Form
- Lyophilized powder
